Synergic effect of oral contraceptives, gstp1 polymorphisms, and high-risk hpv infection in development of cervical lesions

B. S. Chagas, A. P.A.D. Gurgel, S. S.L. Paiva Júnior, R. C.P. Lima, M. N. Cordeiro, R. R. Moura, R. R. Moura, A. V.C. Coelho, K. C.G. Nascimento, J. C. Silva Neto, S. Crovella, S. Crovella, S. Crovella, A. C. Freitas

Research output: Contribution to journalArticlepeer-review


© 2017 The Authors. Human papillomavirus (HPV) infection is considered a risk factor for cervical cancer. Even if the high-risk HPV (HR-HPV) infection is necessary, environmental co-factors and genetic susceptibility also play an important role in cervical cancer development. In this study, a possible association of rs1695 GSTP1 polymorphisms, HR-HPV infection, and oral contraceptive use with cancer lesion development in women was investigated. The study population comprised 441 Brazilian women from the Northeast region including 98 HPV-infec ted women with high-grade squamous intraepithelial lesions, 77 HPV-infected women with low-grade squamous intraepithelial lesions, and 266 HPV-negative women with no lesion, used as a control. Our data did not show a significant association between the GSTP1 polymorphism A/G (rs1695) and any HPV-related cervical abnormalities. However, considering the use of oral contraceptives, the GSTP1 rs1695 polymorphism was associated with higher susceptibility to the development of cervical lesions in HR-HPV-infected women. Our study suggests a synergic effect of oral contraceptive use, GSTP1 polymorphisms, and HR-HPV infection in the development of cervical lesions. Together, these risk factors may induce neoplastic transformation of the cervical squamous epithelium, setting conditions for secondary genetic events leading to cervical cancer.
Original languageEnglish
JournalGenetics and Molecular Research
Issue number3
Publication statusPublished - Aug 17 2017


  • Cervical cancer
  • Contraceptive
  • Glutathione S-transferase
  • Human papillomavirus


Dive into the research topics of 'Synergic effect of oral contraceptives, gstp1 polymorphisms, and high-risk hpv infection in development of cervical lesions'. Together they form a unique fingerprint.

Cite this